Andrew Futreal is a professor and chair in the Department of Genomic Medicine at The University of Texas MD Anderson Cancer Center, studying the genomic underpinnings of cancer with the aim of understanding the contribution of molecular variation to clinical phenotypes in patients. Here, we ask Andy about his longstanding career in the BRCA field, from the initial cloning of BRCA1 in 1994 to the still outstanding questions.
